Skip to content

The stories shaping the United States, Canada, and the world.

BusinessUnited StatesPress release

Kaplan Fox Advises Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Act Before the Lead Plaintiff Deadline on September 28, 2026

NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period”). CLICK […]

Financial Post

Published by CurrentWire · First coverage

Compiled by CurrentWire News Desk

Summary based on reporting from Financial Post.

Read the full report at Financial Post(opens in a new tab)

Automated coverage analysis

Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.

Source mix

1 press release

CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.